Celldex Therapeutics Inc (NASDAQ:CLDX)

0.7001
Delayed Data
As of Apr 20
 +0.021 / +3.09%
Today’s Change
0.65
Today|||52-Week Range
3.42
-75.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
AssetsCash42.5M66.2M54.7M40.3M
 
 
 
 
 
Short Term Investment Cash36.0K23.7M-11.4M-14.4M
 
 
 
 
 
Cash & Short Term Investments166.5M153.6M140.2M139.1M
 
 
 
 
 
 
ReceivablesReceivables1.9M1.8M3.3M2.2M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets5.1M4.7M3.8M3.4M
 
 
 
 
 
Current Assets173.5M160.1M147.3M144.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross------34.0M
 
 
Depreciation-------23.6M
 
 
Intangible Assets172.2M172.0M158.8M158.6M
 
 
 
 
 
Other Assets174.2M174.0M160.8M160.5M
 
 
 
 
 
Total Assets360.0M346.1M319.4M315.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.7M2.0M1.3M1.7M
 
 
 
 
 
Accrued Expenses19.4M21.3M17.8M13.1M
 
 
 
 
 
Other Current Liabilities24.4M26.8M23.6M19.7M
 
 
 
 
 
Other Liabilities27.0M28.8M24.9M27.7M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities85.2M85.8M75.4M51.5M
 
 
 
 
 
Total Liabilities112.2M114.6M100.3M79.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity247.8M231.5M219.2M236.4M
 
 
 
 
 
Total Shareholder Equity247.8M231.5M219.2M236.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding124.2M127.4M132.1M138.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.